Biofrontera (BFRI) Total Non-Current Liabilities (2020 - 2025)

Biofrontera's Total Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $17.7 million for Q4 2025.

• In Q4 2025, Total Non-Current Liabilities rose 8.01% year-over-year to $17.7 million; the TTM figure through Dec 2025 stood at $17.7 million (up 8.01% YoY), while the FY2025 annual figure was $17.7 million, up 8.01% from the prior year.
• Total Non-Current Liabilities was $17.7 million for Q4 2025 at Biofrontera, up from $17.2 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $36.2 million in Q4 2021 to a low of -$8.6 million in Q2 2023.
• Historically, Total Non-Current Liabilities has averaged $20.1 million across 5 years, with a median of $21.2 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Total Non-Current Liabilities plunged 130.38% in 2023, then jumped 213.11% in 2024.
• A 5-year view of Total Non-Current Liabilities shows it stood at $36.2 million in 2021, then slipped by 25.52% to $27.0 million in 2022, then declined by 29.85% to $18.9 million in 2023, then slipped by 13.27% to $16.4 million in 2024, then grew by 8.01% to $17.7 million in 2025.
• The last three Total Non-Current Liabilities figures came in at $17.7 million (Q4 2025), $17.2 million (Q3 2025), and $24.3 million (Q2 2025), per Business Quant data.